Literature DB >> 16923768

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox.

Martin H Strauss1, Alistair S Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923768     DOI: 10.1161/CIRCULATIONAHA.105.594986

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  64 in total

1.  Is there a link between angiotensin receptor blockers and cancer?

Authors:  Frank Enseleit; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

2.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  More about the "ARB MI paradox".

Authors:  Alistair S Hall; Martin H Strauss
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

4.  β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.

Authors:  Dennis M Abraham; Robert T Davis; Chad M Warren; Lan Mao; Beata M Wolska; R John Solaro; Howard A Rockman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

5.  Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.

Authors:  Ken Yajima; Akira Shimada; Hiroshi Hirose; Yoichi Oikawa; Satoru Yamada; Shu Meguro; Junichiro Irie; Seiko Irie
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

6.  Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.

Authors:  Raisa Serpi; Anna-Maria Tolonen; Olli Tenhunen; Oskari Pieviläinen; Anna-Maria Kubin; Tommi Vaskivuo; Ylermi Soini; Risto Kerkelä; Hanna Leskinen; Heikki Ruskoaho
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

Review 7.  Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.

Authors:  Carlos M Ferrario
Journal:  Life Sci       Date:  2009-12-01       Impact factor: 5.037

8.  The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action.

Authors:  Hyoung Kyu Kim; Jae Boum Youm; Sung Ryul Lee; Se Eun Lim; Sun-Young Lee; Tae Hee Ko; Le Thanh Long; Bernd Nilius; Du Nam Won; Jung-Hyun Noh; Kyung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  Pflugers Arch       Date:  2012-10-17       Impact factor: 3.657

Review 9.  Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.

Authors:  Stephan Lüders
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Results of the ONTARGET and TRANSCEND studies: an update and discussion.

Authors:  David Fitchett
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.